Close

BIO Statement on Hepatitis C Medicines Report from Senators Grassley and Wyden

Dec 1 2015

Washington, D.C. (December 1, 2015) – The following statement regarding the report released today by Senators Grassley and Wyden may be attributed to BIO Senior Vice President of...

BIO Statement on EPA Final Rule for 2014, 2015 and 2016 Renewable Fuel Standards

Nov 30 2015
The final rule for the 2014, 2015 and 2016 Renewable Fuel Standards (RFS), issued today by the Environmental Protection Agency (EPA), is an unnecessary, unlawful about face for a program that was successfully driving development of cleaner biofuel technologies and reduction of U.S. greenhouse gas emissions. The rule undermines the goals of the statute, and it will continue to undercut investment in advanced and cellulosic biofuels and increase greenhouse gas emissions in the transportation fuel sector, BIO said today.

BIO Applauds Administration’s Support for Science-based Food Policy

Nov 23 2015
The Food and Drug Administration (FDA) has officially announced that it has rejected petitions from public interest groups calling for mandatory labeling of foods produced with genetic engineering.

BIO Statement on HHS Forum on Pharmaceutical Innovation, Access, Affordability and Better Health

Nov 20 2015

Washington, D.C. (November 20, 2015) – The Biotechnology Industry Organization (BIO) released the following statement regarding today’s U.S. Department of Health and Human Services...

BIO Applauds FDA Approval of GE Salmon, Technology Provides Sustainable, Nutritious Food

Nov 19 2015
After conducting a thorough and rigorous regulatory review, the U.S. Food and Drug Administration (FDA) has approved the genetically engineered (GE) AquAdvantage® Salmon for commercial marketing.

BIO Releases Seven Proposed Topics for HHS Forum on Pharmaceutical Innovation, Access, Affordability and Better Health

Nov 18 2015
BIO released a list of seven proposed topics for the November 20th U.S. Department of Health and Human Services (HHS) Forum on Pharmaceutical Innovation, Access, Affordability and Better Health. The consideration of these topics at the Forum will help to ensure that patients have access to the most innovative new treatments and cures.

Michigan Senator Debbie Stabenow Introduces Legislation That Advances Tax Incentives for Producers of Renewable Chemicals

Nov 13 2015
The Biotechnology Industry Organization (BIO) today thanked Senators Stabenow (D-MI), Coons (D-DE) and Franken (D-MN) for introducing S. 2271, the Renewable Chemicals Act of 2015, a bill to amend the Internal Revenue Code of 1986 to provide credits for the production of renewable chemicals and investments in renewable chemical production facilities.  

New Jersey Governor Christie Signs Bill Ensuring Patient Access to Interchangeable Biologic Medicines

Nov 10 2015
Communication important for Patients and Physicians

BIO Statement on Announced House Democrats' Drug Pricing Task Force

Nov 4 2015

...

BIO Statement on EPA Rule for 2014, 2015 and 2016 Renewable Fuel Standards

Nov 2 2015
If the Environmental Protection Agency (EPA) does not correct its course in its final rule for the 2014, 2015 and 2016 Renewable Fuel Standards (RFS), it will continue to undermine the goals and requirements of the statute, undercut investment in advanced and cellulosic biofuels, and raise greenhouse gas emissions in the transportation fuel sector, the Biotechnology Industry Organization (BIO) said today in reaction to the transmittal of the final rules to the White House Office of Management and Budget for review.